Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.


TSX:SVA - Post by User

Comment by JonEcashon Feb 03, 2021 12:56am
179 Views
Post# 32455437

RE:RE:RE:Short interest

RE:RE:RE:Short interest $1.26 is the 61.8% Fib retracement from $0.26 to $2.87. So seems like a logical place for the share price to bounce from, which it did yesterday and today.

Shorting in the $2's and even high $1's made a lot of sense under cover of technicals, profit-taking, and warrant exercises. A lot of that cover is gone and I agree with others that continuing to do so here is too risky.

Once the shorts start to cover the share price will move up just as easily as it came down, and I don't think that has started yet -at least not in any volume. I'm sure the Company has plenty of news in the pipeline to light the fuse under them.

GLTA

J$ 
<< Previous
Bullboard Posts
Next >>